Pasithea Therapeutics Financials
| KTTA Stock | USD 3.18 0.01 0.31% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.02 | 6.3371 |
|
|
The financial analysis of Pasithea Therapeutics is a critical element in measuring its lifeblood. Investors should not minimize Pasithea Therapeutics' ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Pasithea | Select Account or Indicator |
Understanding current and past Pasithea Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Pasithea Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Pasithea Therapeutics' assets may result in an increase in income on the income statement.
Please note, the presentation of Pasithea Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Pasithea Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Pasithea Therapeutics' management manipulating its earnings.
Pasithea Therapeutics Stock Summary
Pasithea Therapeutics competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, and Transcode Therapeutics. Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida. Pasithea Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 3 people.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US70261F1030 |
| CUSIP | 70261F103 70261F202 |
| Location | California; U.S.A |
| Business Address | 1111 Lincoln Road, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.pasithea.com |
| Phone | 702 514 4174 |
| Currency | USD - US Dollar |
Pasithea Therapeutics Key Financial Ratios
| Return On Equity | -0.63 | ||||
| Price To Sales | 42.15 X | ||||
| Revenue | 486.56 K | ||||
| Gross Profit | (2.21 K) | ||||
| EBITDA | (15.33 M) |
Pasithea Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pasithea Therapeutics's current stock value. Our valuation model uses many indicators to compare Pasithea Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pasithea Therapeutics competition to find correlations between indicators driving Pasithea Therapeutics's intrinsic value. More Info.Pasithea Therapeutics Corp is rated second overall in return on equity category among its peers. It is rated fourth overall in return on asset category among its peers . At present, Pasithea Therapeutics' Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Pasithea Therapeutics' earnings, one of the primary drivers of an investment's value.Pasithea Therapeutics Systematic Risk
Pasithea Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Pasithea Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Pasithea Therapeutics correlated with the market. If Beta is less than 0 Pasithea Therapeutics generally moves in the opposite direction as compared to the market. If Pasithea Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Pasithea Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Pasithea Therapeutics is generally in the same direction as the market. If Beta > 1 Pasithea Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Pasithea Therapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pasithea Therapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Pasithea Therapeutics growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Pasithea Therapeutics November 21, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Pasithea Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pasithea Therapeutics Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pasithea Therapeutics Corp based on widely used predictive technical indicators. In general, we focus on analyzing Pasithea Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pasithea Therapeutics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 68.44 | |||
| Value At Risk | (11.00) | |||
| Potential Upside | 8.27 |
Complementary Tools for Pasithea Stock analysis
When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |